Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia

Shahrzad Mazhari1, Greg Price, Milan Dragović

  • 1Centre for Clinical Research in Neuropsychiatry, Gascoyne House, John XXIII Avenue, Mt. Claremont, Perth, WA 6010, Australia. smazhari@kmu.ac.ir

Brain and Cognition
|September 20, 2011
PubMed